Ovid Therapeutics News - OVID

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Ovid Therapeutics Inc OVID NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.02 0.5% 4.01 4.15 3.98 4.05 3.99 00:00:06
more quote information »

Recent News

Date Time Source Heading
11/27/201913:16EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
11/26/201908:00GLOBEOvid Therapeutics to Participate at the 31st Annual Piper..
11/22/201906:24EDGARStatement of Changes in Beneficial Ownership (4)
11/22/201906:22EDGARAmended Statement of Ownership (sc 13g/a)
11/22/201906:19EDGARInitial Statement of Beneficial Ownership (3)
11/22/201906:17EDGARAmended Statement of Ownership (sc 13g/a)
11/21/201908:59EDGARStatement of Changes in Beneficial Ownership (4)
11/21/201908:58EDGARInitial Statement of Beneficial Ownership (3)
11/18/201916:05GLOBEOvid Therapeutics Appoints Jason Tardio as Chief Commercial..
11/15/201916:29EDGARStatement of Changes in Beneficial Ownership (4)
11/15/201916:27EDGARStatement of Changes in Beneficial Ownership (4)
11/15/201916:25EDGARStatement of Changes in Beneficial Ownership (4)
11/15/201916:23EDGARStatement of Changes in Beneficial Ownership (4)
11/12/201908:03EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/08/201908:24EDGARQuarterly Report (10-q)
11/08/201908:05EDGARCurrent Report Filing (8-k)
11/08/201908:00GLOBEOvid Therapeutics Reports Third Quarter 2019 Financial..
11/04/201917:46EDGARStatement of Changes in Beneficial Ownership (4)
11/04/201917:44EDGARStatement of Changes in Beneficial Ownership (4)
11/01/201908:24EDGARCurrent Report Filing (8-k)
11/01/201908:00GLOBEOvid Therapeutics Announces Senior Management Promotions in..
10/08/201906:03EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
10/08/201906:02EDGARCurrent Report Filing (8-k)
10/08/201906:01EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
10/07/201913:12EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
10/04/201908:30GLOBEOvid Therapeutics Announces Pricing of $32.5 Million of..
10/03/201916:12EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
10/03/201916:10EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
10/03/201916:01GLOBEOvid Therapeutics Announces Proposed Concurrent Public..
9/24/201906:01EDGARCurrent Report Filing (8-k)
9/23/201908:01EDGARCurrent Report Filing (8-k)
9/23/201907:00GLOBEOvid Therapeutics Announces Positive Initial Data from..
9/19/201906:01EDGARCurrent Report Filing (8-k)
9/12/201908:11EDGARCurrent Report Filing (8-k)
9/12/201908:00GLOBEOvid Therapeutics Announces First Patient Randomized in..
9/09/201908:00GLOBEOvid Therapeutics to Present at the H.C. Wainwright 21st..
9/09/201906:02EDGARCurrent Report Filing (8-k)
9/03/201908:00GLOBEOvid Therapeutics Announces Participation in Two Upcoming..
8/07/201917:32EDGARSecurities Registration: Employee Benefit Plan (s-8)
8/07/201917:03EDGARQuarterly Report (10-q)
8/07/201916:40EDGARCurrent Report Filing (8-k)
8/07/201916:05GLOBEOvid Therapeutics Reports Second Quarter 2019 Financial..
8/01/201917:03EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
8/01/201917:01EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
8/01/201917:00EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
7/02/201908:06EDGARCurrent Report Filing (8-k)
7/02/201908:00GLOBEOvid Therapeutics Receives Orphan Drug Designation from the..
6/27/201912:06EDGARCurrent Report Filing (8-k)
6/27/201908:06EDGARCurrent Report Filing (8-k)
6/27/201908:00GLOBEOvid Therapeutics Initiates Pivotal Phase 3 Clinical Trial..
See more news about this stock »


Your Recent History
NASDAQ
OVID
Ovid Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.